WHO ICTRP trial
Three versus five years of adjuvant Imatinib as treatment for patients with…
ACTRN12621001756819 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12621001756819 |
|---|---|
| Public title | Three versus five years of adjuvant Imatinib as treatment for patients with operable gastrointestinal stromal tumour (GIST) with a high risk for recurrence: SSGXXII: A Randomised phase III study |
| Scientific title | Three versus five years of adjuvant Imatinib as treatment for patients with operable gastrointestinal stromal tumour (GIST) with a high risk for recurrence: SSGXXII: A Randomised phase III study |
| Primary sponsor | Australasian Gastro-Intestinal Trials Group (AGITG) |
| Secondary sponsors | Scandinavian Sarcoma Group (SSG) |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia |
| Conditions | Gastrointestinal stromal tumour (GIST); Gastrointestinal stromal tumour (GIST);Cancer - Stomach;Cancer - Oesophageal (gullet);Cancer - Bowel - Anal;Cancer - Bowel - Back passage (rectum) or large bowel (colon);Cancer - Bowel - Small bowel… |
| Interventions | Following completion of 35-38 months of standard of care Imatinib treatment (defined as 200-800mg daily oral tablet), patients will be enrolled and randomised to receive continued Imatinib oral tablets at 400 mg/day for 24 months, or to… |
| Registration date | Dec 22, 2021 |
| Target size | 25 |
| Secondary IDs | Protocol number: CTC 0275;AGITG Protocol Number: AG0221GS |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: